Aarti Drugs tumbled 5.9% to Rs 694 at 13:06 IST on BSE after net profit fell 14.1% to Rs 18.86 crore on 1.5% decline in net sales to Rs 277.61 crore in Q4 March 2015 over Q4 March 2014.
The Q4 result was announced after market hours yesterday, 20 May 2015.
Meanwhile, the S&P BSE Sensex was down 20.45 points or 0.07% at 27,816.76.
On BSE, so far 37,000 shares were traded in the counter as against average daily volume of 18,928 shares in the past one quarter.
The stock hit a high of Rs 716.75 and a low of Rs 676.25 so far during the day. The stock had hit a record high of Rs 874 on 8 April 2015. The stock had hit a 52-week low of Rs 185.50 on 20 May 2014.
The stock had outperformed the market over the past one month till 20 May 2015, rising 1.72% compared with Sensex's 0.18% fall. The scrip had also outperformed the market in past one quarter, advancing 11.7% as against Sensex's 4.77% fall.
More From This Section
The small-cap company has equity capital of Rs 24.22 crore. Face value per share is Rs 10.
Aarti Drugs is a pharmaceutical company. The company makes generic bulk actives, advanced intermediates and specialty chemicals.
Powered by Capital Market - Live News